Antimicrobial Susceptibility Testing
Editat de James A. Poupard, Lori R. Walsh, Bruce Klegeren Limba Engleză Paperback – 22 mai 2013
Preț: 1055.00 lei
Preț vechi: 1110.52 lei
-5%
Puncte Express: 1583
Carte tipărită la comandă
Livrare economică 13-27 iulie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9781475792089
ISBN-10: 1475792085
Pagini: 204
Ilustrații: XI, 191 p.
Dimensiuni: 178 x 254 x 12 mm
Greutate: 0.4 kg
Ediția:Softcover reprint of the original 1st ed. 1994
Editura: Springer
Locul publicării:New York, NY, United States
ISBN-10: 1475792085
Pagini: 204
Ilustrații: XI, 191 p.
Dimensiuni: 178 x 254 x 12 mm
Greutate: 0.4 kg
Ediția:Softcover reprint of the original 1st ed. 1994
Editura: Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1: Current Methods.- The Evolution of Antimicrobial Susceptibility Testing Methods.- Antimicrobial Susceptibility Tests: Testing Methods and Interpretive Problems.- Clinician Utilization of Rapid Antibiotic Susceptibility Data: A Prospective Study.- Session 2: Contemporary Issues in Susceptibility Testing.- When We Should Be Testing, How Often and What to Report.- Areas of Recent Emphasis of the National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility Testing.- Non-Traditional Approaches for Quality Control of Antimicrobial Susceptibility Tests.- Applications of Medical Informatics in Antibiotic Therapy.- Session 3: New and Developmental Methods.- Established Antimicrobial Susceptibility Testing Methods with a New Twist — Points to Consider and a Glimnpse of the Future.- Measures of Susceptibility from a Spiral Gradient of Drug Concentrations.- Commercialization of Nucleic Acid Probe Technology: Current Status.- Session 4: Rapidly Approaching Controversial Issues.- Is One Laboratory In Town Enough?.- The FDA Review Criteria for Assessment of Antimicrobial Susceptibility Devices — Too Much or Not Enough Regulation?.- The Evoulution of Clinical Laboratory Regulation — A Primer for Universal Health Care.- Current Issues in Antimicrobial Susceptibility Testing.- Selected Manuscripts from Poster Presentations.- The Use of In-Vitro Kinetic Models in the Evaluation of ?-Lactam/?-Lactamase Combinations.- Prevalence of Ticarcillin/Clavulanic Acid-Resistant Enterobacteriacaeae in Nine Separate Medical Centers During the Years 1983, 1989, 1991.- Correlation of Minimum Inhibitory Concentration Results Between the Vitek System and the Biomic System.- Contributors.